Myths and Shibboleths in Nephrology

Name: Myths and Shibboleths in Nephrology
Price: 109.99 USD
Availability: InStock
ISBN: 9781402006166

ISBN-10: 1402006160

ISBN-13: 9781402006166

Edition: 2002

Authors: Eli A. Friedman, Iram Anees

List price: $59.99

30 day, 100% satisfaction guarantee!

Marketplace

1 new & used from $109.99

what's this?

Rush Rewards U
Members Receive:

You have reached 400 XP and carrot coins. That is the daily max!

Description:

Increasingly, medicine in general and nephrology specifically is based on clinical trials and verifiable presumption. Still, however, much of everyday clinical practice is the consensus of pundits and experts unable to validate their suggestions beyond personal bias. In this unique volume, several core beliefs in renal medicine are examined and challenged. Starting as assignments for nephrology fellows, this book grew out of surprising `revelations' indicating that `the emperor has no clothes'. The book is suitable as a stimulus for provocative discussions for nephrologists, internists, house staff, and medical students.

Book details

List price: $59.99
Copyright year: 2002
Publisher: Springer
Publication date: 6/30/2002
Binding: Paperback
Pages: 74
Size: 6.25" wide x 9.25" long x 0.25" tall
Weight: 0.396
Language: English



Dedication


Foreword



Preface


Contributors



Urinary tract infection can lead to end stage renal disease (ESRD)




Kidney donation does not jeopardize function in the remaining kidney




Hypertension imposes a risk of chronic kidney failure




Angiotensin converting enzyme inhibitors (ACEi) are superior to other antihypertensive drugs because of their renoprotective properties




Dietary protein restriction slows progression of renal insufficiency




Plasmapheresis is beneficial in some renal disorders




Urinary tract infection is more prevalent in diabetes




Type 1 diabetes is more likely than type 2 diabetes to lead to nephropathy and ESRD




Pharmacological strategies may prevent acute tubular necrosis (ATN)




Intravenous iron may be hazardous in infected hemodialysis patients




Peritoneal dialysis is equivalent to hemodialysis




Rationing of ESRD treatment is an unavoidable reality




Tacrolimus is superior to cyclosporine in renal transplantation




Dialyzer re-use is safe and cost effective




Living related pancreas after kidney transplantation is preferable to cadaveric simultaneous pancreas-kidney transplantation




Administration of active vitamin D metabolites is beneficial in patients with advanced chronic renal failure (pre end-stage renal disease)




Surgical intervention and prompt nephrectomy are preferred in emphysematous pyelonephritis




Mortality in chronic hemodialysis is greater in the U.S. than in Europe and Japan




A single hemodialysis treatment prevents uremic bleeding and restores platelet function




Kidney biopsy is indicated in every care of lupus nephritis




Indicators of glycemic control in diabetic ESRD patients should be equivalent to those utilized in earlier stages of diabetic nephropathy




Fish oil is effective therapy for IgA nephropathy




Physician assistants should replace nephrologists in dialysis units




Patients with severe cerebrovascular accidents (CVA) require long-term bladder catheters




Pre-transplant blood transfusions enhance renal allograft survival




Hemoperfusion is superior to hemodialysis in the treatment of certain poisonings and/or drug overdoses



Epilogue